Finance

Lists
Why is ENTX down 3,86%?
Dive Deeper
ENTX:NASDAQ
Entera Bio Ltd
2,99 US$
-3,86%
(-0,12) 1D
5 ნოე, 16:00:02 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENTX...
Open
3,07 US$
High
3,10 US$
Low
2,90 US$
Mkt. cap
520,03 მლნ.
Avg. vol.
547,56 ათ.
Volume
0,00
52-wk high
4,20 US$
52-wk low
0,91 US$
EPS
-0,35 US$
Beta
1,48
Shares outstanding
173,92 მლნ.
No. of employees
21
Open
3,07 US$
High
3,10 US$
Low
2,90 US$
Mkt. cap
520,03 მლნ.
Avg. vol.
547,56 ათ.
Volume
0,00
52-wk high
4,20 US$
52-wk low
0,91 US$
EPS
-0,35 US$
Beta
1,48
Shares outstanding
173,92 მლნ.
No. of employees
21
News stories
From web sources and news partners
24/7 Wall St.
24/7 Wall St.
·
1 საათის წინ
Tech Stocks Just Had Their Worst Day Since 2020
Yahoo Finance
Yahoo Finance
·
2 საათის წინ
Interface (NASDAQ:TILE) reports sales below analyst estimates in Q3 2026 earnings
CNN
CNN
·
3 საათის წინ
What sparked the stock market’s $2.5 trillion sell-off?
Reuters
Reuters
·
53 წუთის წინ
Nasdaq futures rise after steep AI selloff as chip stocks stabilize
About Entera Bio Ltd
CEO-
Employees21
Founded2009
Headquarters-
SectorHealth Care
Industry-
Websiteenterabio.com
Analyst ratings
Based on 4 analysts giving stock ratings to ENTX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ENTX in the last 3 months.
Highest
Current 2,99 US$
11,00 US$ (+267,89%)
Average
10,00 US$ (+234,45%)
Lowest
9,00 US$ (+201,00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Vamil Divan
Guggenheim
Buy
Initiated
11,00 US$
+267,9%
09/24/2026
Patrick Dolezal
LifeSci Capital
Buy
Initiated
10,00 US$
+234,4%
09/23/2026
Imogen Mansfield
Cantor Fitzgerald
Buy
Initiated
-
-
09/22/2026
David Risinger
Leerink Partners
Buy
Initiated
9,00 US$
+201%
09/18/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
9,00 US$
+201%
06/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,64 მლნ.
1,72 მლნ.
2,25 მლნ.
3,20 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,61 მლნ.
1,32 მლნ.
1,29 მლნ.
1,36 მლნ.
Operating expense
3,26 მლნ.
3,04 მლნ.
3,54 მლნ.
4,56 მლნ.
Total operating expenses
3,26 მლნ.
3,04 მლნ.
3,54 მლნ.
4,56 მლნ.
Operating income
-3,26 მლნ.
-3,04 მლნ.
-3,54 მლნ.
-4,56 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
-3,20 მლნ.
-3,02 მლნ.
-3,50 მლნ.
-7,31 მლნ.
EBT excluding unusual items
-3,20 მლნ.
-3,02 მლნ.
-3,50 მლნ.
-7,31 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,20 მლნ.
-3,02 მლნ.
-3,50 მლნ.
-7,31 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
56,00 ათ.
26,00 ათ.
34,00 ათ.
-
Interest expense
-
-
-
-2,75 მლნ.
Net interest expenses
56,00 ათ.
26,00 ათ.
34,00 ათ.
-2,75 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,25 მლნ.
-3,04 მლნ.
-3,53 მლნ.
-4,55 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები